Table 3. Clinical characteristics and laboratory results of the neonates.
| Confirmed ( n = 15) | Suspected ( n = 17) | Control ( n = 16) | p -Value | |
|---|---|---|---|---|
| Gender (male/female) | 9/6 | 9/8 | 6/10 | |
| Apgar's score at 5 min median (IQR) | 9 (8–9) | 9 (8–9) | 9 (8–10) | |
| SGA, n (%) | 0 (0) | 0 (0) | 0 (0) | |
| Birthweight, g Mean ± SD |
3,001 ± 321 | 3,452 ± 339 | 3,048 ± 378 |
0.009
a
0.78 b 0.016 c |
|
White blood cell (×10
9
cells/L)
Mean ± SD |
14.11 ± 4.34 | 17.97 ± 7.18 | 16.33 ± 7.32 | 0.254 |
|
Lymphocytes (×10
9
cells/L)
Mean ± SD |
4.01 ± 1.19 | 3.72 ± 1.27 | 3.94 ± 1.22 | 0.860 |
|
Neutrophil (×10
9
cells/L)
Mean ± SD |
8.39 ± 3.04 | 12.40 ± 4.43 | 10.58 ± 4.99 | 0.121 |
| Hemoglobin (g/dL) Mean ± SD |
174.47 ± 19.42 | 179.53 ± 32.09 | 177.69 ± 15.81 | 0.829 |
|
Platelets (×10
9
cells/L)
Mean ± SD |
233.47 ± 62.44 | 285.71 ± 40.5 | 260.44 ± 42.13 | 0.062 |
| C-reactive protein (g/L) Mean ± SD |
0.97 ± 0.88 | 1.92 ± 2.25 | 2.98 ± 4.18 | 0.952 |
| Alanine transaminase (IU/L) Mean ± SD |
13 ± 6.53 | 11.94 ± 6.51 | 12 ± 4.75 | 0.937 |
| Aspartate transaminase (IU/L) Mean ± SD |
47.8 ± 22.27 | 77.12 ± 61.37 | 52 ± 19.75 | 0.659 |
| Urea (μmol/L) Mean ± SD |
2.91 ± 0.78 | 3.58 ± 0.78 | 3.06 ± 1.00 | 0.182 |
| Creatinine (μmol/L) Mean ± SD |
59.93 ± 6.88 | 65.71 ± 14.43 | 57.88 ± 11.78 | 0.399 |
| Cystatin C (mg/L) Mean ± SD |
1.89 ± 0.14 | 1.74 ± 0.23 | 1.81 ± 0.15 | 0.716 |
| Urinary β2 microglobulin (mg/L) Mean ± SD |
3.20 ± 1.03 | 3.45 ± 1.71 | 3.62 ± 1.10 | 0.942 |
| NT-proBNP (pg/mL) Mean ± SD |
2,253 ± 1317.7 | 5,278.9 ± 4186.8 | 3,062.8 ± 1591.3 | 0.459 |
| Cardiac troponin I (ug/L) Mean ± SD |
12.83 ± 6.42 | 33.41 ± 28.49 | 46.46 ± 21.65 | 0.176 |
Abbreviations: NT-proBNP, N-terminal pro-brain natriuretic peptide; IQR, interquartile range; SD, standard deviation.
a
Confirmed group with suspected group.
b
Confirmed group with control group.
c
Suspected group with control group.